Information
15 Pangyo-ro 228beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, South Korea
+82 31-702-2225
-
-
Overview
- Summary
- A company specializing in the development and manufacturing of advanced equipment for biomedical and bioprocess fields, based on ultra-precision optical technology. A bio-materials, parts, and equipment (Soubujang) expert, uniquely developing, manufacturing, and selling single-use bioreactors in Korea. Engaged in diverse businesses including POCT (Point-of-Care Testing) and biomedical analysis systems. Aiming to lead the global bio-medical market through 3rd generation precision medical total solutions.A company specializing in the development and manufacturing of advanced equipment for biomedical and bioprocess fields, based on ultra-precision optical technology. A bio-materials, parts, and equipment (Soubujang) expert, uniquely developing, manufacturing, and selling single-use bioreactors in Korea. Engaged in diverse businesses including POCT (Point-of-Care Testing) and biomedical analysis systems. Aiming to lead the global bio-medical market through 3rd generation precision medical total solutions.
- Key Products/Technologies
- Single Use Bioreactor System: CELBIC (Cellbic) is equipment applying Orbital Rocking technology, achieving high mixing efficiency with low shear stress. Possessing proprietary technology to directly develop and manufacture 3D disposable culture bags in various capacities from 1L to 1,000L. OrbTec is a single-use bioreactor developed through a strategic alliance with Parker Hannifin in the US. Equipment demonstrating superior cell growth and viability compared to conventional methods.Single Use Bioreactor System: CELBIC (Cellbic) is equipment applying Orbital Rocking technology, achieving high mixing efficiency with low shear stress. Possessing proprietary technology to directly develop and manufacture 3D disposable culture bags in various capacities from 1L to 1,000L. OrbTec is a single-use bioreactor developed through a strategic alliance with Parker Hannifin in the US. Equipment demonstrating superior cell growth and viability compared to conventional methods.
- Biomedical Analysis Systems: MD-FR is a fully automated immunoassay system based on Chemiluminescent Enzyme Immunoassay (CLEIA). MD-GENE is a molecular diagnostic system automating the entire process from nucleic acid extraction to PCR. Diamond is a fully automated immunoassay diagnostic device. MDGen is a high-volume COVID-19 antibody diagnostic kit. Laboratory analysis equipment including spectrophotometers (Nabi, Mobi) capable of measuring nucleic acid concentration from trace samples and microplate readers.Biomedical Analysis Systems: MD-FR is a fully automated immunoassay system based on Chemiluminescent Enzyme Immunoassay (CLEIA). MD-GENE is a molecular diagnostic system automating the entire process from nucleic acid extraction to PCR. Diamond is a fully automated immunoassay diagnostic device. MDGen is a high-volume COVID-19 antibody diagnostic kit. Laboratory analysis equipment including spectrophotometers (Nabi, Mobi) capable of measuring nucleic acid concentration from trace samples and microplate readers.
- Core Technologies: Product development based on modular design, offering ease of repair and maintenance, and excellent space utilization. Capabilities in developing high-sensitivity analysis and diagnostic equipment through absorbance, fluorescence, and luminescence optical signal processing technology. Technology to enhance efficiency by automating complex manual experimental steps. Ability to achieve ultra-high sensitivity performance and provide accurate, precise results based on fluid dynamic structural design, surface treatment original technology, and optical signal processing technology. World's first Active Pump Technology for POCT, enabling repetitive washing. Nucleic acid extraction technology to easily extract nucleic acids from various samples with a single cartridge, automating the entire process.Core Technologies: Product development based on modular design, offering ease of repair and maintenance, and excellent space utilization. Capabilities in developing high-sensitivity analysis and diagnostic equipment through absorbance, fluorescence, and luminescence optical signal processing technology. Technology to enhance efficiency by automating complex manual experimental steps. Ability to achieve ultra-high sensitivity performance and provide accurate, precise results based on fluid dynamic structural design, surface treatment original technology, and optical signal processing technology. World's first Active Pump Technology for POCT, enabling repetitive washing. Nucleic acid extraction technology to easily extract nucleic acids from various samples with a single cartridge, automating the entire process.
- Core Advantages
- Unique Development and Commercialization of Single-Use Bioreactors: A pioneering company that first localized and launched integrated single-use bioreactors in Korea. A key player contributing to the localization of biopharmaceutical production processes.Unique Development and Commercialization of Single-Use Bioreactors: A pioneering company that first localized and launched integrated single-use bioreactors in Korea. A key player contributing to the localization of biopharmaceutical production processes.
- Proprietary Technology and R&D Capabilities: Possession of Orbital Rocking technology, achieving high mixing efficiency with low shear stress. Technical capability to directly develop and manufacture 3D disposable culture bags. High investment in R&D, with 42% of all employees being R&D personnel.Proprietary Technology and R&D Capabilities: Possession of Orbital Rocking technology, achieving high mixing efficiency with low shear stress. Technical capability to directly develop and manufacture 3D disposable culture bags. High investment in R&D, with 42% of all employees being R&D personnel.
- Establishment of a Stable Revenue Model: A 'Razor-Blade' business model supplying dedicated diagnostic kits and consumables along with equipment sales. A long-term, cumulative revenue model through consumable replacement and additional orders.Establishment of a Stable Revenue Model: A 'Razor-Blade' business model supplying dedicated diagnostic kits and consumables along with equipment sales. A long-term, cumulative revenue model through consumable replacement and additional orders.
- Global Market Expansion and Partnerships: Strategic alliances with global companies such as Parker Hannifin in the US and Accumax Lab Devices in India. Entering a growth phase by establishing a core market triangle in the Middle East, US, and India.Global Market Expansion and Partnerships: Strategic alliances with global companies such as Parker Hannifin in the US and Accumax Lab Devices in India. Entering a growth phase by establishing a core market triangle in the Middle East, US, and India.
- Recognition of Technological Prowess by Government and Industry: Designated as an innovative product by the Ministry of Trade, Industry and Energy (MOTIE) and selected as an excellent corporate research institute. Recipient of the IR52 Jang Young-sil Award in the 'Diamond' category. First bio equipment company to be selected as a 'Soubujang (materials, parts, equipment) Master Company'.Recognition of Technological Prowess by Government and Industry: Designated as an innovative product by the Ministry of Trade, Industry and Energy (MOTIE) and selected as an excellent corporate research institute. Recipient of the IR52 Jang Young-sil Award in the 'Diamond' category. First bio equipment company to be selected as a 'Soubujang (materials, parts, equipment) Master Company'.
- Applicability to Advanced Biopharmaceuticals: Bioreactor technology applicable to gene and cell therapies, unlike existing global products optimized for antibody therapeutics. Potential to preempt the domestic market for bioreactors used in advanced biopharmaceutical production.Applicability to Advanced Biopharmaceuticals: Bioreactor technology applicable to gene and cell therapies, unlike existing global products optimized for antibody therapeutics. Potential to preempt the domestic market for bioreactors used in advanced biopharmaceutical production.
- Target Industries
- Biopharmaceutical Manufacturing and Development: Supply of bioreactors, key equipment in biopharmaceutical production facilities. Culturing and proliferation of cells, the main components of various biopharmaceuticals such as gene and cell therapies.Biopharmaceutical Manufacturing and Development: Supply of bioreactors, key equipment in biopharmaceutical production facilities. Culturing and proliferation of cells, the main components of various biopharmaceuticals such as gene and cell therapies.
- In-Vitro Diagnostics (IVD) and Medical Diagnostics: Development and supply of automated in-vitro diagnostic systems for rapid and accurate disease diagnosis. Maximizing diagnostic efficiency and accuracy in medical institutions and research laboratories.In-Vitro Diagnostics (IVD) and Medical Diagnostics: Development and supply of automated in-vitro diagnostic systems for rapid and accurate disease diagnosis. Maximizing diagnostic efficiency and accuracy in medical institutions and research laboratories.
- Life Science Research and Lab Automation: Provision of automated analysis systems to enhance data accuracy and reproducibility in research and production sites. Increasing research efficiency by automating complex manual experimental steps.Life Science Research and Lab Automation: Provision of automated analysis systems to enhance data accuracy and reproducibility in research and production sites. Increasing research efficiency by automating complex manual experimental steps.
- Vaccine Production and Green Bio Industry: Supply of single-use bioreactors to the world's largest vaccine manufacturers. Utilization as core equipment for the development, demonstration, and production of next-generation biopharmaceuticals, including green vaccines.Vaccine Production and Green Bio Industry: Supply of single-use bioreactors to the world's largest vaccine manufacturers. Utilization as core equipment for the development, demonstration, and production of next-generation biopharmaceuticals, including green vaccines.
- Contract Manufacturing Organizations (CMO) and Contract Development and Manufacturing Organizations (CDMO): Supply of products to domestic and international CMO and CDMO companies. Supporting enhanced production efficiency and quality through bio-process automation solutions.Contract Manufacturing Organizations (CMO) and Contract Development and Manufacturing Organizations (CDMO): Supply of products to domestic and international CMO and CDMO companies. Supporting enhanced production efficiency and quality through bio-process automation solutions.
- Major Markets
- India, ChinaIndia, China
- United StatesUnited States
- Certifications/Patents
- Patents: Acquired a patent related to disposable cell culture bags (2019). Acquired a patent related to 3rd generation precision Point-of-Care Testing (POCT) (2020). Acquired a US patent for 'CELL CULTURE SYSTEM' (2023). Patent for temperature control device. Patent for fluorescence and luminescence measurement device. Patent for automatic sealing device for biological liquid sample extraction/sealing tubes.Patents: Acquired a patent related to disposable cell culture bags (2019). Acquired a patent related to 3rd generation precision Point-of-Care Testing (POCT) (2020). Acquired a US patent for 'CELL CULTURE SYSTEM' (2023). Patent for temperature control device. Patent for fluorescence and luminescence measurement device. Patent for automatic sealing device for biological liquid sample extraction/sealing tubes.
- Certifications: ISO 13485:2016 (Medical Device Quality Management System). ISO 9001:2015 (Quality Management System). Europe CE certification. Innovative Small and Medium Business (Inno-Biz) certification. Small and Medium Business Administration Venture Company certification (New Technology Company). Designated as an innovative product by the Ministry of Trade, Industry and Energy.Certifications: ISO 13485:2016 (Medical Device Quality Management System). ISO 9001:2015 (Quality Management System). Europe CE certification. Innovative Small and Medium Business (Inno-Biz) certification. Small and Medium Business Administration Venture Company certification (New Technology Company). Designated as an innovative product by the Ministry of Trade, Industry and Energy.
Introduction
Location
15 Pangyo-ro 228beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, South Korea
클릭하여 위치 살펴보기
